Publications

Search our bibliography using the filters on the right-hand side.

Displaying 151 through 200 of 347 publications.

Chiang J, Schwab P, McCulloch R, Brooks P, Rhodes C, Happe L. Impact of a retrospective drug utilization review program on changing opioid prescribing behavior. Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 23, 2018. Boston, MA. [abstract] J Manag Care Pharm. 2018 Apr; 24(4-a):S11.

Sacco P, Raspa M, Leahy L, Cabo R. A literature review of the economic burden of Fragile X syndrome. Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 23, 2018. Boston, MA. [abstract] J Manag Care Pharm. 2018 Apr; 24(4-a):S7. Previously presented at the 70th AAN Annual Meeting.

Darden C, Mitra D, McSorley D, Davis K, Band J, Iyer S. Patient-reported treatment satisfaction among women receiving palbociclib combination therapies for HR+/HER2- advanced or metastatic breast cancer in the United States. Poster presented at the 35th Annual Miami Breast Cancer Conference; March 8, 2018. Miami Beach, FL.

Magrey M, Wolin DL, Mordin MM, McLeod LD, Davenport EK, Hur P. US patient satisfaction with Secukinumab treatment among patients with both psoriatic arthritis and psoriasis: data from a web-based survey. Poster presented at the 2018 Winter Clinical Dermatology Conference; January 2018. Hawaii. [abstract] Skin: the journal of cutaneous medicine. 2018 Feb 23; 2(2018). doi: 10.25251/skin.2.supp.25

Critchlow C, Chinn C, Price MA. Blurring the division between clinical and observational studies. Presented at the 9th Annual SCOPE Summit Conference; February 13, 2018. Orlando, FL.

Price MA, Richardson D. Value of conducting feasibility studies in observational research. Presented at the 9th Annual SCOPE Summit Conference; February 13, 2018. Orlando, FL.

Devercelli G, Davis K, Brown M, Hollis K, Hunter S, Long J, Jain G, Banerji A. Burden of hereditary angioedema: findings from a US patient survey. Poster presented at the 2018 AAAAI/WAO Joint Congress; March 3, 2018. Orlando, FL. [abstract] J Allergy Clin Immunol. 2018 Feb; 141(2 Suppl):AB57. doi: 10.1016/j.jaci.2017.12.182

Mandeville K, Valentic M, Ivankovic D, Pristas I, Long J, Patrick H. Quality assurance of registries for health technology assessment. Int J Technol Assess Health Care. 2018;34(4):360-7.

Douglas AG, Schwab P, Lane D, Kennedy K, Slabaugh SL, Bowe A. A comparison of brand and biosimilar granulocyte-colony stimulating factors for prophylaxis of chemotherapy-induced febrile neutropenia. J Manag Care Spec Pharm. 2017 Dec;23(12):1221-6. doi: 10.18553/jmcp.2017.23.12.1221

Maurer M, Abuzakouk M, Berard F, Canonica W, Oude Elberink H, Gimenez-Arnau A, Grattan C, Hollis K, Knulst A, Lacour JP, Lynde C, Marsland A, McBride D, Nakonechna A, Ortiz De Frutos J, Proctor C, Sussman G, Sweeney C, Tian H, Weller K, Wolin D, Balp M-M. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU. Allergy. 2017 Dec;27(12):2005-16. doi: 10.1111/all.13209

Levine CA, Ansquer V. Ethical considerations: conducting retrospective non-interventional medical record review studies in Europe. Poster presented at the 2017 ISPOR 20th Annual European Congress; November 8, 2017. Glasgow, Scotland.

Wheeler AC, Sacco P, Cabo R. Unmet clinical needs and burden in Angelman syndrome: a review of the literature. Orphanet J Rare Dis. 2017 Oct 16;12(1):164. doi: 10.1186/s13023-017-0716-z

Davis KH, Su J, Gonzalez JM, Trudeau JT, Nelson LM, Hauber B, Hollis KA. Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat. Health Qual Life Outcomes. 2017 Oct 16;15(1):201. doi: 10.1186/s12955-017-0780-z

Grimes R, Grant L, Kaur S, Spencer H, Brookes B, Bennett B. Evaluating patient reported outcomes commonly used in current lung cancer clinical trials. Value Health. 2017 Oct 1;20(9):PA764.

Sluga-O'Callaghan M, Ansquer V, Frugier G, Mai C. Regulatory requirements for non-interventional studies collecting patient preferences and experiences in France, Germany and the UK. Poster presented at the 2017 ISPOR 20th Annual European Congress; November 2017. Glasgow, Scotland. [abstract] Value Health. 2017 Oct; 20(9):A707.

Davis KH, Asiimwe A, Zografos LJ, McSorley DJ, Andrews EB. Evaluation of risk-minimization activities for cyproterone acetate 2 mg/ethinylestradiol 35 μg: a cross-sectional physician survey. Pharmaceut Med. 2017 Oct;31(5):339-51. doi: 10.1007/s40290-017-0203-9

Bonner N, Hall R, Tritton T, Grimes R, Trennery C, Spencer H, Bennett B. Rare diseases, are caregivers just as affected as patients? Value Health. 2017 Oct 1;20(9):PA562.

Banerji A, Davis KH, Devercelli G, Hollis K, Hunter S, Jain G. Clinical and demographic characteristics of patients with hereditary angioedema in the United States. Poster presented at the American College of Allergy, Asthma, and Immunology 2017 Annual Scientific Meeting; October 2017. Boston, MA.

Spencer H, Grant L, Kaur S, Grimes R, Brookes B, Bennett B. Special considerations for conducting qualitative interviews with cancer patients and their caregivers for the purpose of developing clinical outcome assessments. Poster presented at the 2017 ISPOR 20th Annual European Conference; November 2017. Glasgow, Scotland. [abstract] Value Health. 2017 Oct; 20(9):A777. doi: 10.1016/j.jval.2017.08.2247

Quittner AL, Alpern AN, Wolin D, McLeod L, Downey C, Nelson L, Khandelwal N. Psychometric analyses of a new GI symptom tracker for cystic fibrosis. Poster presented at the 31st Annual North American Cystic Fibrosis Conference; September 19, 2017. Indianapolis, IN. [abstract] Pediatr Pulmonol. 52(S47):453.

Quittner AL, Alpern AN, Wolin D, McLeod L, Downey C, Nelson L, Khandelwal N. Pysychometric analyses of a new GI symptom tracker for cystic fibrosis. Poster presented at the 31st Annual North American Cystic Fibrosis Conference; November 2, 2017. Indianapolis, IN. [abstract] Pediatr Pulmonol. 2017 Sep 19; 52(S47):S453. doi: 10.1002/ppul.23840

Sussman G, Abuzakouk M, Berard F, Canonica GW, Gimenez-Arnau A, Grattan C, Hollis K, Khalil S, Knulst AC, Lacour J-P, Lynde C, Marsland A, Maurer M, McBride D, Nakonechna A, Ortiz De Frutoz FJ, Oude Elberink JNG, Reynolds M, Weller K, Balp M-M. Angioedema in patients with chronic spontaneous urticaria has an additional impact of quality of life but is reported more often by patients than physicians. Presented at the 26th EADV Congress; September 16, 2017. Geneva, Switzerland.

Strober B, Zhao Y, Herrera V, Wolin D, McLeod L, Eid D, Bello T. Secukinumab provides greater symptom control in psoriasis-related pain, itching, and scaling compared with previous treatments: evidence from a real-world study in the US. Poster presented at the 26th EADV Congress; September 13, 2017. Geneva, Switzerland.

Strober B, Zhao Y, Herrera V, Wolin D, McLeod L, Davenport E, Bello T. Secukinumab patients achieve high overall treatment satisfaction and psoriasis-related and symptom improvement in a real world setting. Presented at the 26th EADV Congress; September 13, 2017. Geneva, Switzerland.

Setji T, Hopkins TJ, Jimenez M, Manning E, Shaughnessy M, Schroeder R, Mendoza-Lattes S, Spratt S, Westover J, Aronson S. Rationalization, development, and implementation of a preoperative diabetes optimization program designed to improve perioperative outcomes and reduce cost. Diabetes Spectr. 2017 Aug;30(3):217-23.

Zografos LJ, Andrews EB, Wolin DL, Calingaert B, Davenport EK, Hollis KA, Petraro P, Djokanovic N, Racanelli VS, Vassilev Z. Evaluating physician knowledge of safety information for aflibercept (Eylea). Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):592. doi: 10.1002/pds

Raspa M, Sacco P, Bailey DB, Visootak J, Cabo R. Clinical unmet needs and burden in fragile X syndrome: results of a targeted literature review. Poster presented at the American Association on Intellectual and Development Disabilities 141st Annual Meeting; June 27, 2017. Hartford, CT.

Marsland A, Abuzakouk M, Balp M-M, Berard F, Canonica GW, Gimenez-Arnau A, Grattan C, Hollis K, Hunter S, Khalil S, Knulst AC, Lacour L-P, Lynde C, McBride D, Nakonechna A, Ortiz De Frutoz FJ, Oude Elberink JNG, Sussman G, Tian H, Weller K, Maurer M. Chronic spontaneous/idiopathic urticaria patients with moderate activity have similar burden of disease as those with severe activity - results from the ASSURE-CSU study. Presented at the EAACI Congress 2017; June 20, 2017. Helsinki, Finland.

Gimenez-Arnau A, Abuzakouk M, Balp M-M, Berard F, Canonica GW, Grattan C, Hollis K, Hunter S, Khalil S, Knulst AC, Lacour J-P, Lynde C, Marsland A, McBride D, Nakonechna A, Ortiz De Frutoz FJ, Oude Elberink JNG, Sussman G, Tian H, Weller K, Maurer M. Economic and humanistic burden associated with angioedema in patients with chronic spontaneous/idiopathic urticaria. Poster presented at the EAACI Congress 2017; June 20, 2017. Helsinki, Finland.

Nabbout R, Auvin S, Cross JH, Guerrini R, Scheffer I, Thiele E, Chiron C, Irwin J, Mistry A, Williamson N, Grimes R, Bennett B. Cultural relevance of the global impact of Dravet Syndrome in Australia, Italy, the US and UK. Eur J Paediatr Neuro. 2017 Jun 1;21(Suppl 1):E187. doi: 10.1016/j.ejpn.2017.04.777

Sluga-O'Callaghan M, Derrien Ansquer V, Mai C. Evolution of regulatory requirements for retrospective observational studies using medical records in France, Germany, Spain and the UK. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(2017):A68.

Schwab P, Dhamane AD, Hopson SD, Moretz C, Annavarapu S, Burslem K, Renda A, Kaila S. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2017 Feb 23;12:735-44. doi: 10.2147/COPD.S112256

Price MA, Hamm L. Synergies in the operationalization of clinical and observational studies. Presented at the 8th Annual SCOPE Summit Conference; January 24, 2017. Miami, FL.

Dhamane AD, Schwab P, Hopson S, Moretz C, Annavarapu S, Burslem K, Renda A, Kaila S. Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016 Dec 22;12:115-22. doi: 10.2147/COPD.S114802

McRoy LL, Mitra D, Hollis K, Kaye JA, Zelnak A, Cheryl J. MADELINE: a prospective observational study of mobile-app based patient reported outcomes in advanced breast cancer. Poster presented at the 2016 San Antonio Breast Cancer Symposium; December 9, 2016. San Antonio, TX.

Balp M, Abuzakouk M, Berard F, Canonica GW, Gimenez-Arnau A, Hollis K, Khalil S, Knulst A, Lacour J, Lynde C, Marsland A, Maurer M, McBride D, Nakonechna A, Ortiz De Frutoz FJ, Oude Elberink J, Proctor C, Sussman G, Weller K, Grattan C. Comparison of direct healthcare costs associated with chronic spontaneous/idiopathic urticaria in 7 countries - results from the ASSURE-CSU study. Poster presented at the 2016 ISPOR 19th Annual European Congress; November 1, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A565.

Wheeler A, Sacco P, Rakhit A, Cabo R. Identifying the unmet medical need of Angelman Syndrome: results of a targeted literature review. Poster presented at the 2016 ISPOR 19th Annual European Congress; November 1, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A579.

Hollis K, Abuzakouk M, Balp M, Berard F, Canonica GW, Gimenez-Arnau A, Grattan C, Khalil S, Knulst AC, Lacour J, Lynde C, Maurer M, McBride D, Nakonechna A, Ortiz De Frutos J, Oude Elberink J, Proctor C, Sussman G, Sweeney C, Tian H, Weller K, Marsland A. Assessing health-utility values for chronic spontaneous/idiopathic urticaria in real-world using the EQ-5D: results from ASSURE-CSU study. Poster presented at the 2016 ISPOR 19th Annual European Congress; November 1, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A570-1.

Gamble JF, Kurian DJ, Hopkins TJ, Guinn NR, Grimsley A, Jimenez M, Aronson S. Preoperative anemia clinic: optimizing hemoglobin for elective hip and knee arthroplasty. Poster presented at the American Society of Anesthesiologists 2016 Annual Conference; October 25, 2016. Chicago, IL.

Ray N, Hopkins TJ, Jimenez M, Buchheit T, Aronson S. Providing perioperative value: multidisciplinary telehealth optimization of spine surgery chronic pain patients. Poster presented at the American Society of Anesthesiologists 2016 Annual Conference; October 24, 2016. Chicago, IL.

Lamon A, Peterson-Layne C, Cooter M, Grimsley A, Swamy G, Hopkins TJ, Aronson S, Jimenez M, Guinn NR. Value of a preoperative anemia clinic in a high-risk obstetric population. Poster presented at the American Society of Anesthesiologists 2016 Annual Conference; October 23, 2016. Chicago, IL.

Prakken SD, Kipnes J, Hopkins TJ, Freiermuth C, Jimenez M, Shinar E, Buchheit T, Aronson S. Impacting ED utilization in high-risk chronic pain patients; The Pain Assessment Risk Treatments for Novel Effective Recovery (PARTNER) program. Poster presented at the American Society of Anesthesiologists 2016 Annual Conference; October 23, 2016. Chicago, IL.

Kurian DJ, Gamble JF, Hopkins TJ, Guinn NR, Grimsley A, Jimenez MI, Aronson S. Preoperative blood management strategy for elective hip and knee arthroplasty: preliminary findings. Poster presented at the American Society of Anesthesiologists 2016 Annual Conference; October 22, 2016. Chicago, IL.

Mease P, Schwab PE, Dinh H, Sheer R, Cappelleri J, Bananis E, Harnett J, Hsu MA. Treatment patterns, health care resource utilization, and costs associated with psoriatic arthritis among Humana commercial and Medicare member populations. Poster presented at the 2016 Academy of Managed Care Pharmacy's 28th Annual Meeting & Expo; October 3, 2016. National Harbor, MD.

Swanger C, Tobbe C, Schwab PE, Lane D, Hurwitch A. Opioid utilization patterns in a humana commercial and medicare population. Poster presented at the 2016 Academy of Managed Care Pharmacy's 28th Annual Meeting & Expo; October 3, 2016. National Harbor, MD. [abstract] J Manag Care Pharm. 2016 Oct; 22(10-a).

Kulak AN, Grimes R, Kim YY, Semsarilar M, Anduix-Canto C, Cespedes O, Armes SP, Meldrum FC. Polymer-directed assembly of single crystal zinc oxide/magnetite nanocomposites under atmospheric and hydrothermal conditions. Chem Mater. 2016 Sep;28(20):7528-36. doi: 10.1021/acs.chemmater.6b03563

Raspa M, Sacco P, Candrilli SD, Bishop E, Petrillo J. Validity of a condition specific outcome measure for fragile X syndrome: the Aberrant Behaviour Checklist-utility index. J Intellect Disabil Res. 2016 Sep;60(9):844-55. doi: 10.1111/jir.12264

Bailey RA, Schwab P, Xu Y, Pasquale M, Renda A. Glycemic control outcomes after Canagliflozin initiation: observations in a Medicare and commercial managed care population in clinical practice. Clin Ther. 2016 Sep;38(9):2046-2057. doi: 10.1016/j.clinthera.2016.07.009

Marion S, Tzivelekis S, Darden C, Price MA, Sherif B, Garcia J, Kaye JA, Chandler D. "Same-day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale. Support Care Cancer. 2016 Sep;24(9):3889-96. doi: 10.1007/s00520-016-3193-3

Lewis JH, Whelihan K, Navarro I, Boyle KR, SDH Card Study Implementation Team. Community health center provider ability to identify, treat and account for the social determinants of health: a card study. BMC Fam Pract. 2016 Aug 27;17(1):121. doi: 10.1186/s12875-016-0526-8